Related Experiment Video
Updated: Jul 14, 2026
A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
Exploring the role of mitochondrial dysfunction-related genes in osteoporosis using weighted gene co-expression
Han-Bing Zeng1, Xiang-Tao Yuan2, Lian-Guo Wu1
1Orthopedics and Traumatology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, 310005, Zhejiang, China.
Background:
Osteoporosis (OP) is a prevalent age-related disease characterized by bone loss and increased fracture risk. Mitochondrial dysfunction is tightly associated with OP pathogenesis. This study aimed to explore the role of mitochondrial dysfunction-related genes (MDRGs) in OP.
Methods:
Differentially expressed genes (DEGs) were identified from OP transcriptomic data sets, and weighted gene co-expression network analysis was performed to determine OP-associated modules. Machine learning algorithms (Random Forest, Support Vector Machine, and Lasso) were applied to identify hub MDRGs. Gene set enrichment analysis (GSEA) and regulatory network analysis were performed to elucidate their functions and regulatory interactions. Hub gene's expression was validated in tissues using immunofluorescence, and osteogenic induction assays were conducted to validate the biological role and mechanism of the key gene VPS35 in osteoblast differentiation.
Results:
ALAS1, HSPB1, and VPS35 were identified as hub MDRGs, with VPS35 showing good diagnostic performance. GSEA highlighted potential molecular pathways associated with hub genes in OP, such as TNF-NFκB, RAS-ERK, and RAS-PI3K signaling pathways. In addition, a regulatory network involving hub genes, miRNAs, and lncRNAs was preliminarily constructed, providing insights into possible regulatory mechanisms underlying OP. Experimental validation demonstrated that VPS35 overexpression inhibited osteoblast differentiation by suppressing the ERK/PI3K/AKT signaling pathways, and this progression was regulated by miR-142-5p.
Conclusions:
This study reveals the potential roles of MDRGs in OP pathogenesis. VPS35 acts as a negative regulator of osteogenic differentiation by inhibiting ERK and PI3K/AKT signaling, providing preliminary insights into mitochondrial regulation of bone metabolism and potential therapeutic targets for OP.
